|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Prepaid research and development expenses | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accrued expenses and other current liabilities | ||||||||||||||||||||
| Related party accounts payable and other current liabilities | ||||||||||||||||||||
| Deposit liability | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Operating lease liability, current | ||||||||||||||||||||
| Warrant liability, related party | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long term liabilities | ||||||||||||||||||||
| Operating lease liability, noncurrent | ||||||||||||||||||||
| Notes payable, noncurrent | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes payable, noncurrent | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Series Seed convertible preferred stock, $0.0001 par value; no shares and 20,000,000 shares authorized as of December 31, 2025 and December 31, 2024, respectively; no shares and 20,000,000 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively; liquidation preference of $0 and $4,000 as of December 31, 2025 and December 31, 2024, respectively | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Non-voting convertible preferred shares, $0.001 par value; 5,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 2,890 Series A designated shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Total non-voting convertible preferred shares, $0.001 par value; 5,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 2,890 Series A designated shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Ordinary shares, $0.001 par value; 175,000,000 shares authorized as of June 30, 2026 and December 31, 2025, 27,756,044 and 27,556,767 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
